172 related articles for article (PubMed ID: 35779403)
1. Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer's disease.
Velueta-Viveros M; Martínez-Bailén M; Puerta A; Romero-Hernández LL; Křen V; Merino-Montiel P; Montiel-Smith S; Fernandes MX; Moreno-Vargas AJ; Padrón JM; López Ó; Fernández-Bolaños JG
Bioorg Chem; 2022 Oct; 127():105983. PubMed ID: 35779403
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-Assisted Synthesis of Piperidinyl-Quinoline Acylhydrazones as New Anti-Alzheimer's Agents: Assessment of Cholinesterase Inhibitory Profile, Molecular Docking Analysis, and Drug-like Properties.
Munir R; Zaib S; Zia-Ur-Rehman M; Hussain N; Chaudhry F; Younas MT; Zahra FT; Tajammul Z; Javid N; Dera AA; Ogaly HA; Khan I
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903376
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design of new N-benzyl-piperidine derivatives as multitarget-directed AChE/BuChE inhibitors for Alzheimer's disease.
Conceição RAD; von Ranke N; Azevedo L; Franco D; Nadur NF; Kummerle AE; Barbosa MLC; Souza AMT
J Cell Biochem; 2023 Nov; 124(11):1734-1748. PubMed ID: 37796142
[TBL] [Abstract][Full Text] [Related]
4. Discovery of New 1,3,4-Oxadiazoles with Dual Activity Targeting the Cholinergic Pathway as Effective Anti-Alzheimer Agents.
Elghazawy NH; Zaafar D; Hassan RR; Mahmoud MY; Bedda L; Bakr AF; Arafa RK
ACS Chem Neurosci; 2022 Apr; 13(8):1187-1205. PubMed ID: 35377601
[TBL] [Abstract][Full Text] [Related]
5. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
[TBL] [Abstract][Full Text] [Related]
6. A review on cholinesterase inhibitors for Alzheimer's disease.
Anand P; Singh B
Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
[TBL] [Abstract][Full Text] [Related]
7. Biphenylalkoxyamine Derivatives-Histamine H
Łażewska D; Zaręba P; Godyń J; Doroz-Płonka A; Frank A; Reiner-Link D; Bajda M; Stary D; Mogilski S; Olejarz-Maciej A; Kaleta M; Stark H; Malawska B; Kieć-Kononowicz K
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208297
[TBL] [Abstract][Full Text] [Related]
8. Indoloquinoxaline derivatives as promising multi-functional anti-Alzheimer agents.
Kanhed AM; Patel DV; Patel NR; Sinha A; Thakor PS; Patel KB; Prajapati NK; Patel KV; Yadav MR
J Biomol Struct Dyn; 2022 Apr; 40(6):2498-2515. PubMed ID: 33111617
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Study of Benzimidazole-Based Oxazole Analogues: A Promising Acetylcholinesterase and Butyrylcholinesterase Inhibitors.
Hussain R; Rahim F; Ullah H; Khan S; Sarfraz M; Iqbal R; Suleman F; Al-Sadoon MK
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894494
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterases: new roles in brain function and in Alzheimer's disease.
Giacobini E
Neurochem Res; 2003 Apr; 28(3-4):515-22. PubMed ID: 12675140
[TBL] [Abstract][Full Text] [Related]
12. Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors.
Roldán-Peña JM; Romero-Real V; Hicke J; Maya I; Franconetti A; Lagunes I; Padrón JM; Petralla S; Poeta E; Naldi M; Bartolini M; Monti B; Bolognesi ML; López Ó; Fernández-Bolaños JG
Eur J Med Chem; 2019 Nov; 181():111550. PubMed ID: 31376562
[TBL] [Abstract][Full Text] [Related]
13. Structure-based discovery and development of novel O-GlcNAcase inhibitors for the treatment of Alzheimer's disease.
Li X; Han J; Bujaranipalli S; He J; Kim EY; Kim H; Im JH; Cho WJ
Eur J Med Chem; 2022 Aug; 238():114444. PubMed ID: 35588599
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
[TBL] [Abstract][Full Text] [Related]
15. Dual targeting of cholinesterase and amyloid beta with pyridinium/isoquinolium derivatives.
Chakravarty H; Ju Y; Chen WH; Tam KY
Drug Dev Res; 2020 Apr; 81(2):242-255. PubMed ID: 31837041
[TBL] [Abstract][Full Text] [Related]
16. Search for new multi-target compounds against Alzheimer's disease among histamine H
Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B
Eur J Med Chem; 2020 Jan; 185():111785. PubMed ID: 31669851
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
[TBL] [Abstract][Full Text] [Related]
18. Novel N-benzylpiperidine derivatives of 5-arylisoxazole-3-carboxamides as anti-Alzheimer's agents.
Saeedi M; Felegari P; Iraji A; Hariri R; Rastegari A; Mirfazli SS; Edraki N; Firuzi O; Mahdavi M; Akbarzadeh T
Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000258. PubMed ID: 33226157
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]